ArticleFrontiers in nutrition2025
Sarcopenia and quality of life in patients with diabetes mellitus type 2 in a maternal and child center.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the relationship between sarcopenia and quality of life in patients with type 2 diabetes mellitus in a mother and child center, Peru 2024. Methods: The research was applied, non-experimental, relational, where work was done in 295 diabetic patients. Regarding the technique, observation was used, recording data on a data collection form, and the survey technique was applied, where the SF-36 questionnaire was administered. Grip strength was measured using the Jamar hydraulic dynamometer and the measurement method according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2). Results: Normal grip strength was most represented at 57.29%, followed by low grip strength at 42.71% using the EGWSOP criterion. On the other hand, according to the JAMAR method, low grip strength was 61.69%. Regarding quality of life, the average level was obtained (27.12%), high (26.10%), followed by the very high level (18.98%). In addition, a significant correlation was determined between the dimensions of physical function, physical role, bodily pain perception, general health, vitality, social function, emotional role, and mental health of quality of life and sarcopenia ( Conclusion: It is concluded that there was a positive and significant correlation between sarcopenia and quality of life in patients with type 2 diabetes mellitus for both the EGWSOP criterion (r = 0.303) and the JAMAR method (r = 0.306) (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.